Jocabed Roldán

Statistics

Publications

Citations

263

H-Index

Active since

2014

Affiliations

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer(Current)

Universitat de Barcelona

Hospital Clínic de Barcelona

Universidad de Oviedo

Jocabed Roldán is an author at Consorci Institut D'Investigacions Biomediques August Pi I Sunyer specializing in oncology, medicine, and molecular oncology.

Publications per year

2014–2019

Publications

The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells

Mònica López‐Guerra, Sílvia Xargay‐Torrent, Laia Rosich et al. · Leukemia · 2014 · 69 citations · Full text

Medicine, Cancer Biology, Oncology +14

The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia

Sílvia Xargay‐Torrent, Mònica López‐Guerra, Laia Rosich et al. · Oncotarget · 2015 · 68 citations · Full text

Medicine, Oncology, Pharmacology +12

CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemia

Arnau Montraveta, Eriong Lee‐Vergés, Jocabed Roldán et al. · Oncotarget · 2015 · 36 citations · Full text

Medicine, Oncology, Pharmacology +16

Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma

Laia Rosich, Arnau Montraveta, Sílvia Xargay‐Torrent et al. · Oncotarget · 2014 · 35 citations · Full text

Medicine, Hematology, Oncology +17

Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells

Mònica López‐Guerra, Sílvia Xargay‐Torrent, Patricia Fuentes et al. · Oncogene · 2019 · 33 citations · Full text

Medicine, Hematology, Oncology +12

1–5 of 7